For more than 40 years, at Adium we have consolidated a wide range portfolio to offer physicians and patients innovative and high-quality therapeutic solutions in Latin America, aimed at improving the quality of life of the population within the region. The company encompasses multiple therapeutic areas to provide the best treatment therapies throughout Latin America.
Cardiovascular diseases are the leading cause of death worldwide, and also in most countries of the Americas. Adium offers a wide portfolio for hypertension, hypercholesterolemia, anticoagulation treatment.
Diabetes has become one of the leading causes of death and disability within the region of the Americas. We have products for the treatment of type I and type II Diabetes.
Pain treatment aims at improving the quality of life in patients, and reducing their suffering caused by pain. Our portfolio offers leading molecules for the treatment of pain in severe and chronic illnesses.
Rare Diseases (RA) as an emerging concept, defines low prevalence, high severity and debilitating chronic diseases that affect multiple systems and organs.
Gastroenterological diseases attack the stomach and intestines. This can be caused by bacteria, parasites, viruses and some foods, although it may also be caused by some medicines. For both peptic ulcer disease and irritable bowel syndrome we have effective molecule treatment.
Gynecology is a medicine specialty that focuses on the study of the female reproductive system. Women's healthcare is one of the objectives capped by our products, and we have a wide range of oral contraceptives and devices.
Treats diseases in the blood and related organs such as bone marrow, lymph nodes and spleen. The main pathologies are anemia, thrombopathies, lymphomas, hemophilia, leukemia. We represent biotech companies that develop innovative molecules for patient treatment.
Immune disorders cause the malfunctioning of our immune system, responsible for defense against infections. Among the most common immune diseases are rheumatoid arthritis, multiple sclerosis and myasthenia gravis. Our portfolio includes target molecule drugs for the treatment of these pathologies.
Neurological disorders are diseases in the central and peripheral nervous system. For the treatment of patients with Alzheimer's disease, as well as Epilepsies and Parkinson's we have the most modern and effective molecules.
Obesity is a complex disease characterized by excess body fat. It is not only an aesthetic problem. For the treatment of obesity, we have a range of different molecules and combinations that contribute to achieve the stated objective.
Oncological diseases are the second cause of death in industrialized countries. Periodic medical examination and early diagnosis, greatly reduce their severity. We offer a wide range portfolio for different types of cancer treatment that can affect the lungs, breasts, pancreas or bile ducts.
Osteoarticular (Joints and bones)
This group of diseases represent all the pathologies involving deterioration and dysfunction of the bone and joint system. For degenerative joint disease treatment, we provide successful combinations, as well as viscosupplementation devices.
Osteoporosis has been considered the main cause of morbility in elderly patients due to disabilities and in hospitalizations. For the treatment of osteoporosis and osteopenia, we offer an innovative portfolio, in both prevention and improvement, as well as fracture risk reduction.
Psychiatric disorders, are diseases manifested mainly as thought, emotion or behavior disorders, causing discomfort or a functional deficiency. We provide multiple therapeutic alternatives for the treatment of many psychiatric conditions.
Urological diseases affect the urinary system causing disorders and infections in the urinary tract such as the bladder. For the treatment of hyperactive bladder, benign prostatic hyperplasia, as well as erectile dysfunction, our portfolio has the latest medications in the specialty.